What is the ticker symbol for MediciNova?

MediciNova trades under the ticker MNOV on NASDAQ.

What sector does MediciNova operate in?

MediciNova is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze MNOV in a portfolio?

PortView shows MNOV's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

MediciNova (MNOV) Stock Analysis

NASDAQHealthcareBiotechnology

$1.45+0.35%

1-year price historyRange $1.18 – $1.88

52-week range$1.45

$1.17$1.96

What MediciNova does

MediciNova, Inc. is a biopharmaceutical firm dedicated to discovering and advancing innovative small molecule therapies for severe illnesses where current treatments are insufficient within the United States. Its robust development pipeline features MN-166 (ibudilast), an oral agent with both anti-inflammatory and neuroprotective properties, currently being investigated for a range of neurological conditions. These include primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and various forms of substance dependence and addiction. The company's portfolio also comprises MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist aimed at treating acute asthma attacks; MN-001 (tipelukast), an orally available small molecule designed for fibrotic disorders like nonalcoholic steatohepatitis and idiopathic pulmonary fibrosis; and MN-029 (denibulin), a tubulin binding agent intended for solid tumor oncology. MediciNova has established strategic partnerships with companies such as Kissei Pharmaceutical Co., Ltd., Kyorin Pharmaceutical Co., Ltd., Angiogene Pharmaceuticals Ltd., and Meiji Seika Kaisha Ltd. Established in 2000, the company's headquarters are situated in La Jolla, California.

Key metrics

Market cap

$71.12M

P/E (TTM)

-6.88

EPS (TTM)

$-0.21

Beta

0.62

Dividend yield

0.00%

Revenue / share

$0.02

50-day avg

$1.37

200-day avg

$1.43

52-week high

$1.96

52-week low

$1.17

CEO

Yuichi Iwaki

ETFs linked to MNOV

Broad-market and Healthcare sector ETFs an investor holding MediciNova is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how MNOV fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze MNOV in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for MediciNova?: MediciNova trades under the ticker MNOV on NASDAQ.
Which exchange is MNOV listed on?: MNOV is listed on NASDAQ.
What sector does MediciNova operate in?: MediciNova is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze MNOV in a portfolio?: PortView shows MNOV's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.